🔗 Permalink

Inventor profile of:

Patrick Hoffmann

City:

Munich

Country:

Germany

Published Applications:

Last publication date:

2026-05-14

Top Assignees for applications by Patrick Hoffmann

The entities that hold a legal rights for patent applications filed by inventor Hoffmann Patrick:

AMGEN RESEARCH (MUNICH) GMBH 33 Munich, Germany
Amgen Inc. 13 Thousand Oaks, CA United States
BOEHRINGER INGELHEIM INTERNATIONAL GMBH 2 Ingelheim am Rhein, Germany
Boehringer Ingellheim iInternational Gmbh 1 Ingelheim am Rhein, Germany
Amegen Research (Munich) GmbH 1 Muncih, Germany

Recent patent applications by Hoffmann Patrick

Patrick Hoffmann from Munich, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-14

US20260132199A1

Chemistry; metallurgy

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

#2 | 2026-04-30

US20260116972A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD3, EPCAMXCD3, IGF-1RXCD3 OR FAPALPHAXCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

#3 | 2025-11-13

US20250346684A1

Chemistry; metallurgy

BINDING MOLECULES FOR BCMA AND CD3

#4 | 2025-11-06

US20250340639A1

Chemistry; metallurgy

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

#5 | 2025-10-30

US20250333537A1

Chemistry; metallurgy

PSMA AND CD3 BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

#6 | 2025-10-30

US20250333535A1

Chemistry; metallurgy

BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCT WITH ENHANCED TISSUE DISTRIBUTION

#7 | 2025-09-11

US20250282863A1

Chemistry; metallurgy

ANTIBODY CONSTRUCTS FOR MSLN AND CD3

#8 | 2025-05-22

US20250163179A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

#9 | 2025-05-22

US20250163177A1

Chemistry; metallurgy

BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

#10 | 2025-03-20

US20250092133A1

Chemistry; metallurgy

BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3

#11 | 2024-12-05

US20240400673A1

Chemistry; metallurgy

ANTIBODY CONSTRUCTS FOR MSLN AND CD3

#12 | 2024-02-15

US20240052300A1

Chemistry; metallurgy

DIFFUSION GRADIENT ASSAY FOR ANTI-CD3-CONTAINING MOLECULES

#13 | 2024-01-11

US20240010724A1

Chemistry; metallurgy

Antibody Constructs for CDH19 and CD3

#14 | 2023-10-05

US20230312717A1

Chemistry; metallurgy

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

#15 | 2023-08-31

US20230272113A1

Chemistry; metallurgy

ANTIBODY CONSTRUCTS FOR FLT3 AND CD3

#16 | 2023-06-22

US20230192884A1

Chemistry; metallurgy

BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

#17 | 2023-02-23

US20230057728A1

Chemistry; metallurgy

LONG LIFE POLYPEPTIDE BINDING MOLECULES

#18 | 2023-02-09

US20230041876A1

Chemistry; metallurgy

Bispecific antibody constructs for CDH3 and CD3

#19 | 2022-12-22

US20220403035A1

Chemistry; metallurgy

MULTITARGETING ANTIGEN-BINDING MOLECULES FOR USE IN PROLIFERATIVE DISEASES

#20 | 2022-11-10

US20220356268A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#21 | 2022-08-11

US20220251243A1

Chemistry; metallurgy

BINDING MOLECULES FOR BCMA AND CD3

#22 | 2022-03-03

US20220064336A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#23 | 2022-03-03

US20220064308A1

Chemistry; metallurgy

Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3

#24 | 2022-02-10

US20220041736A1

Chemistry; metallurgy

Cross-species-specific single domain bispecific single chain antibody

#25 | 2021-10-07

US20210309743A1

Chemistry; metallurgy

Antibody constructs for DLL3 and CD3

#26 | 2021-09-16

US20210284748A1

Chemistry; metallurgy

ANTIBODY CONSTRUCTS FOR CD70 AND CD3

#27 | 2021-03-11

US20210070878A1

Chemistry; metallurgy

PSMA and CD3 Bispecific T Cell Engaging Antibody Constructs

#28 | 2020-11-19

US20200362039A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD3, EPCAMXCD3, IGF-1RXCD3 OR FAPALPHAXCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

#29 | 2020-10-22

US20200332002A1

Chemistry; metallurgy

Antibody constructs for DLL3 and CD3

#30 | 2020-05-07

US20200140558A1

Chemistry; metallurgy

Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3

#31 | 2020-03-26

US20200095319A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS

#32 | 2020-03-05

US20200071405A1

Chemistry; metallurgy

ANTIBODY CONSTRUCTS FOR CDH19 AND CD3

#33 | 2020-02-13

US20200048357A1

Chemistry; metallurgy

BCMA and CD3 bispecific T cell engaging antibody constructs

#34 | 2020-02-06

US20200040099A1

Chemistry; metallurgy

Single chain binding molecules comprising N-terminal ABP

#35 | 2019-08-29

US20190263907A1

Chemistry; metallurgy

Antibody constructs for DLL3 and CD3

#36 | 2019-06-06

US20190169310A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

#37 | 2019-06-06

US20190169295A1

Chemistry; metallurgy

LONG LIFE POLYPEPTIDE BINDING MOLECULES

#38 | 2019-01-17

US20190016805A1

Chemistry; metallurgy

Antibody constructs for CDH19 and CD3

#39 | 2018-05-24

US20180142021A1

Chemistry; metallurgy

Bispecific antibody constructs for CDH3 and CD3

#40 | 2018-01-04

US20180002450A1

Chemistry; metallurgy

Antibody constructs for CDH19 and CD3

#41 | 2017-12-07

US20170349668A1

Chemistry; metallurgy

Optimized cross-species specific bispecific single chain antibody contructs

#42 | 2017-11-16

US20170327581A1

Chemistry; metallurgy

Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains

#43 | 2017-09-28

US20170275373A1

Chemistry; metallurgy

BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCT WITH ENHANCED TISSUE DISTRIBUTION

#44 | 2017-08-03

US20170218079A1

Chemistry; metallurgy

PSMA and CD3 bispecific T cell engaging antibody constructs

#45 | 2017-08-03

US20170218078A1

Chemistry; metallurgy

Bispecific T cell engaging antibody constructs

#46 | 2017-08-03

US20170218077A1

Chemistry; metallurgy

BCMA and CD3 bispecific T cell engaging antibody constructs

#47 | 2017-05-11

US20170129961A1

Chemistry; metallurgy

Antibody constructs for CD70 and CD3

#48 | 2017-02-09

US20170037149A1

Chemistry; metallurgy

Antibody constructs for FLT3 and CD3

#49 | 2017-02-09

US20170037130A1

Chemistry; metallurgy

Antibody constructs for DLL3 and CD3

#50 | 2017-02-02

US20170029512A1

Chemistry; metallurgy

Antibody constructs for EGFRVIII and CD3

#51 | 2017-02-02

US20170029502A1

Chemistry; metallurgy

Antibody constructs for MSLN and CD3

#52 | 2016-06-23

US20160176973A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#53 | 2016-06-02

US20160152707A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS

#54 | 2016-05-05

US20160122436A1

Chemistry; metallurgy

SINGLE CHAIN BINDING MOLECULES COMPRISING N-TERMINAL ABP

#55 | 2016-02-04

US20160032019A1

Chemistry; metallurgy

Antibody constructs for CDH19 and CD3

#56 | 2015-12-24

US20150368343A1

Chemistry; metallurgy

Antibody constructs for CDH19 and CD3

#57 | 2015-02-05

US20150037334A1

Chemistry; metallurgy

LONG LIFE POLYPEPTIDE BINDING MOLECULES

#58 | 2015-01-22

US20150023967A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#59 | 2014-11-27

US20140348837A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#60 | 2014-10-30

US20140322218A1

Chemistry; metallurgy

Antibody Constructs for CDH19 and CD3

#61 | 2013-06-20

US20130156770A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#62 | 2013-06-20

US20130156769A1

Chemistry; metallurgy

Binding molecules for BCMA and CD3

#63 | 2013-05-23

US20130129730A1

Chemistry; metallurgy

Cross-species-specific PSMAxCD3 bispecific single chain antibody

#64 | 2012-02-09

US20120034228A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

#65 | 2011-12-01

US20110293619A1

Chemistry; metallurgy

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

InventorID:

260848 ⎘